Integrated assessment of women’s health. The multi-organ screening test focused on hormonal changes at this stage of life provides an initial overview of women’s health. By combining 29 laboratory parameters with personal information, body measurements, vital signs and lifestyle habits, it explores haematological, iron-related, cardiometabolic, thyroid, vitamin D and kidney abnormalities. Its purpose is to provide an integrated view of factors related to bone health, abdominal adiposity and wellbeing during this stage of life.
High-resolution comprehensive assessment of the hematopoietic system and bone marrow. By cross-analysing the blood count, red cell indices (MCV, MCH and RDW), and iron metabolism (ferritin), the system helps assess microcytic, normocytic or macrocytic anaemia and deficiency-related anaemia related to iron, as well as blood count patterns associated with chronic processes, haemolysis or genetic traits such as thalassaemia minor.
Assessment of the innate and adaptive immune response. The differential white blood cell count breakdown acts as a biological indicator that offers clear evidence of active bacterial or viral infections, agranulocytosis, systemic allergic responses, hypereosinophilic syndromes of parasitic origin, or immunosuppressive states.
Ultra-specific study of platelets and their volumetric indices (MPV and PDW) whose findings allow for early identification of thrombocytopenia (bleeding risk), autoimmune destruction (ITP), or reactive or essential thrombocytosis.
Comprehensive cardiometabolic risk stratification. As a starting point, the algorithm combines anthropometric indices —primarily body mass index (BMI), waist-to-hip ratio (WHR) and waist-to-height ratio (WHtR), alongside parameters such as hypertriglyceridaemic waist (HTGW), lipid accumulation product (LAP), body adiposity index (BAI), visceral adiposity index (VAI) and conicity index (CI)— with the lipid profile, blood pressure and lifestyle habits when the required data are available. This multiparametric assessment helps evaluate underlying metabolic syndrome and contextualise cardiovascular risk.
Advanced characterization of atherosclerotic risk and vascular health. The test assesses atherogenic burden through the atherogenic coefficient (AC), atherogenic index of plasma (AIP), Castelli risk indices I and II, and triglyceride-to-HDL-c index (THI), calculated from the available lipid parameters. This approach supports assessment of dyslipidaemia and silent lipid metabolism abnormalities.
Assessment of carbohydrate metabolism. Glucose measurement helps identify blood glucose abnormalities and guide assessment of hypoglycaemia, hyperglycaemia and possible carbohydrate metabolism disorders, alongside clinical history and sampling conditions.
Mapping of glandular function and feedback loops. TSH measurement allows review of possible thyroid dysfunction and guides assessment of the thyroid regulatory axis alongside symptoms and clinical history.
Assessment of the parathyroid axis and calcium metabolism. Assessment of vitamin D, calcium, albumin and phosphorus helps assess calcium metabolism abnormalities, changes in mineral balance and vitamin D deficiency.
Hormonal changes at this stage of life. FSH is interpreted alongside age, symptoms, treatments and menstrual history to put hormonal changes into context. The study may help explore factors contributing to mood changes or concentration difficulties, but does not aim to determine whether a woman has reached menopause or provide a comprehensive assessment of her hormonal function.
Renal filtration and glomerular function. Creatinine, together with age and clinical information, allows estimation of glomerular filtration when the required data are available. Interpretation helps assess kidney function abnormalities alongside clinical history and metabolic context.
Fluid and Electrolyte Balance. Assessment of calcium, albumin and phosphorus provides information on mineral balance and its relationship with kidney and endocrine function, guiding evaluation of changes in calcium and phosphorus metabolism.
